GEFRIERGETROCKNETE ARIPIPRAZOLFORMULIERUNG

European patent · EP2717859 · In force

Register entry

Publication number
EP2717859
Application number
EP12731189
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 7, 2012
Published
Apr 16, 2014
Granted
Aug 31, 2016
Protection ends at the latest
Jun 6, 2032
Next annual fee due
Jun 30, 2027
IPC classes
A61K 9/16 (2006.01)
A61K 9/19 (2006.01)
Priority
US 201161494088 P 07.06.2011
PCT application
PCT/JP2012/065180 07.06.2012
PCT publication
WO2012/169662 13.12.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  6. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  7. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  8. Aug 31, 2016

    Granted

    Published in Swissreg on 31.08.2016

Parties

Holder

Otsuka Pharmaceutical Co., Ltd.

9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535, JP

Inventor

HIRAOKA, Shogo

Osaka-shi Osaka 541-0045, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.